期刊文献+

百日咳毒素S1亚基片段在大肠杆菌中的表达

Expression of S1 Subunit Fragment of Pertussis Toxin in E. coli
原文传递
导出
摘要 目的构建百日咳毒素(PT)S1亚基片段原核表达质粒,并在大肠杆菌中表达重组蛋白。方法根据GenBank中登录的百日咳毒素S1亚基基因序列,人工合成密码子优化的S1基因,利用重叠PCR技术将S1基因上的两段DNA序列拼接在一起,形成一个新的基因序列S1′。将该序列与7ZTS表达载体连接,构建重组原核表达质粒7ZTS-S1′,转化大肠杆菌JM109(DE3),IPTG诱导表达。表达产物经SDS-PAGE和Western blot进行鉴定。结果S1′基因经PCR鉴定及测序证明与预期相符;重组表达质粒经双酶切鉴定证明构建正确;表达蛋白的相对分子质量约17400,表达量约占菌体总蛋白的8%,且具有良好的反应原性。结论已成功构建百日咳毒素S1亚基片段重组原核表达质粒,并在大肠杆菌中表达了重组蛋白,为PT单抗及其检测试剂盒的研制奠定了基础。 Objective To construct a prokaryotic expression vector for the S1 subunit fragment of pertussis toxin(PT)and express in E. coli. Methods A S1 gene fragment with E. colipreferred codon was synthesized according to the S1 gene sequence reported in GenBank,based on which a new gene sequence S1′ was obtained through splicing the two DNA sequences of S1 gene by overlap PCR and inserted into expression vector 7ZTS. The constructed recombinant plasmid 7ZTS-S1′ was transformed to E. coli JM109 (DE3)for expression under induction of IPTG. The expressed product was identified by SDS-PAGE and Western blot. Results The PCR and sequencing result of S1′ gene was identical to those expected. Restriction map proved that recombinant plasmid 7ZTS-S1′ was constructed correctly. The expressed product,with a relative molecular mass of about 17 400,contained about 8% of total somatic protein and showed good reactogenicity. Conclusion The prokaryotic expression vector of S1 subunit fragment of pertussis toxin was successfully constructed and expressed in E. coli,which laid a foundation of preparation of PT McAb as well as detection kit for PT.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第4期320-322,共3页 Chinese Journal of Biologicals
基金 吉林省科技发展重点项目(20070924-01).
关键词 百日咳毒素 S1亚基 原核表达 重叠PCR Pertussis toxin(PT) S1 subunit Prokaryotic expression Overlap PCR
  • 相关文献

参考文献10

二级参考文献25

  • 1田效恩,荆瑞芳.吸附精制百日咳菌苗人体接种反应及血清学效果...[J].中华流行病学杂志,1993,14(3):155-159. 被引量:16
  • 2.中国生物制品规程[Z].,2000.66—67.
  • 3Barbieri JT, Moloney BK, MenderMueller LM. Expression and secretion of the S-1 subunit and C180 peptide of pertussis toxin in Escherichia coli. J Bacteriol, 1989, 171(8): 4362-4369.
  • 4Kamachi K, Konda T, Arakawa Y. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice. Vaccine, 2003, 21(31 ): 4609-4615.
  • 5Medeiros MA, ArmSa GR, Dellagostin OA, et al. Induction of humoral immunity in response to immunization with recombinant Mycobacterium boris BCG expressing the S1 subunit of Bordetella pertussis toxin. Can J Microbiol, 2005, 51( 12): 1015-1020.
  • 6Stein PE, Boodhoo A, Armstrong DG, et al. The crystal structure of pertussis toxin. Structure, 1994, 2( 1 ): 45-57.
  • 7Decker MD,et al.Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics, 1995,96: 557 - 566.
  • 8Camille L,Witold C,Kevin S, et al.Activities of complete and truncated forms of Pertussis toxin subunits S1 and S2 synthesized by Escherichia coli. Infect Immun, 1987,55:2546 - 2553.
  • 9Halpern SA,Isskutz TB, Kasina A. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin. J Infect Dis,, 1991,163:355 -361.
  • 10Askelof P, K Rodmalm G, Wrangsell U,et al. Protective immunogenicity of two synthetic peptides selected from the zmino acid sequence of Bordetella petussis toxin subunit Sl.Proc Netl Acad Sci USA,1990,87:1347- 1351.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部